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hepatocyte-like cells (HLC) offers the perspective of unlimited 447, 101, and 505 genes failed to reach levels of hepatocytes.
supply of human hepatocytes. However, the degree of differenti-
ation of HLC remains controversial. To obtain an unbiased charac-
terization, we performed a transcriptomic study with HLC
derived from human embryonic and induced stem cells (ESC,
hiPSC) from three different laboratories.
Methods: Genome-wide gene expression proﬁles of ESC and HLC
were compared to freshly isolated and up to 14 days cultivated
primary human hepatocytes. Gene networks representing suc-
cessful and failed hepatocyte differentiation, and the transcrip-
tion factors involved in their regulation were identiﬁed.
Results: Gene regulatory network analysis demonstrated that
HLC represent a mixed cell type with features of liver, intestine,
ﬁbroblast and stem cells. The ‘‘unwanted’’ intestinal features
were associated with KLF5 and CDX2 transcriptional networks.
Cluster analysis identiﬁed highly correlated groups of genes asso-
ciated with mature liver functions (n = 1057) and downregulated
proliferation associated genes (n = 1562) that approach levels ofJournal of Hepatology 20
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factors.Key TF of two of these clusters include SOX11, FOXQ1, and
YBX3. The third unsuccessful cluster, controlled by HNF1, CAR,
FXR, and PXR, strongly overlaps with genes repressed in culti-
vated hepatocytes compared to freshly isolated hepatocytes, sug-
gesting that current in vitro conditions lack stimuli required to
maintain gene expression in hepatocytes, which consequently
also explains a corresponding deﬁciency of HLC.
Conclusions: The present gene regulatory network approach
identiﬁes key transcription factors which require modulation to
improve HLC differentiation.
 2015 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.Introduction
Primary human hepatocytes represent a well-established tool in
pharmacology and toxicology [1] and have been applied for
transplantation in metabolic liver diseases [2]. However, a major
limitation is availability, since primary hepatocytes have to be
isolated from surgically resected liver tissue [1]. Recently, proto-
cols have been established and optimized to generate
hepatocyte-like cells (HLC) from human embryonic stem cells
(ESC) or human-induced pluripotent stem cells (hiPSC) [3–7],
and human-induced pluripotent stem cells (hiPSC) [8,9]. These
protocols ﬁrst differentiate the ESC or hiPSC into endodermal
cells that are then further differentiated into hepatoblasts and
HLC. These HLC express markers and functions of mature hepato-
cytes such as albumin (ALB) and transthyretin (TTR), and urea
synthesis [7,4,9]. HLC present advantages over primary15 vol. 63 j 934–942
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Abbreviation Expanded description
ESC-MRC Embryonic stem cells from MRC
HLC-MRC-D17 Hepatic-like cells from MRC, 17 days of differentiation
HLC-MRC-D21 Hepatic-like cells from MRC, 21 days of differentiation
ESC-CEL Embryonic stem cells from Cellartis
hiPSC-CEL Human-induced pluripotent stem cells from Cellartis
HLC-ESC-CEL Hepatic-like cells after differentiation of ESC from Cellartis
HLC-hiPSC-CEL Hepatic-like cells after differentiation of hiPSC from Cellartis
ESC-UKK1 Embryonic stem cells from University of Cologne (batch 1)
ESC-UKK2 Embryonic stem cells from University of Cologne (batch 2)
Stem 
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Definitive
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Hepatoblast HLC
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hepatocytes in terms of low batch-to-batch variation and, in prin-
ciple, unlimited supply.
A limitation of the currently available characterizations of HLC
derived from ESC or hiPSC is that they are usually based on a
selected set of markers [10]. Furthermore, little is known about
the transcriptional regulatory networks controlling the differenti-
ation program. With the rationale that identiﬁcation of subopti-
mal gene networks represents a tractable target for improving
cell phenotype, we performed a whole genome gene array study,
including the starting ESC or hiPSC populations from three differ-
ent research centers, as well as the correspondingly differentiated
HLC, and compared them to freshly isolated primary human hep-
atocytes. Two approaches were used to dissect the gene regula-
tory networks (GRN) controlling successful and undesired
outcomes. First, we used the novel CellNet platform to determine
the state and identity of differentiation in HLC, and to estimate
control mechanisms by transcription factors (TF) represented
by ‘‘network inﬂuence scores’’ [11]. Second, we generated gene
clusters based on common expression patterns, and identiﬁed
transcriptional regulators (i.e. TF) associated with each cluster.
In addition, we showed a high correlation between genes with
minimal upregulation in HLC and genes downregulated during
cultivation of primary human hepatocytes, suggesting that the
microenvironment of current culture systems is partly responsi-
ble for the insufﬁcient differentiation of HLC.
In summary, we present evidence, based on unbiased bioinfor-
matic analyzes, that HLC derived from ESC and hiPSC represent a
mixed cell population and/or an intermediate cell type with fea-
tures of liver, ESC, colon or ﬁbroblasts. Moreover, we deﬁne a tran-
scriptional regulatory framework that canbeused fordevelopment
ofmature and homogeneous hepatocyte populations in the future.HLC-UKK total Hepatic-like cells obtained after differentiation of ESC, U. Cologne
HLC-UKK foci Hepatic-like cells obtained after differentiation of ESC, U. Cologne
Fig. 1. Overview of stem cell differentiation protocols and gain of albumin
expression in HLC. (A) Schematic representation of cultivation conditions of stem
cells to achieve a HLC phenotype in the three research centers involved in this
study. (B) Fluorescent microscopy imaging of ESC and differentiated HLC from
MRC stained with antibodies against albumin. The expression of albumin (green)
can be detected uniformly in HLC after 17 days of differentiation. The speciﬁcity
of the staining is conﬁrmed by the absence of green color in HLC stained with IgG
control antibodies. Nuclei are stained with DAPI (blue). Scale bars correspond to
100 lm. (C) Description of abbreviations and expanded description of all ESC and
HLC models used in the current study.Materials and methods
Human ESC cultivation and differentiation into HLC
For the present study, HLC were available from three different centers: University
Klinik Köln, Germany (UKK), Medical Research Council Centre for Regenerative
Medicine, Edinburgh UK (MRC) and Cellartis, Gothenburg, Sweden (CEL). The
human ESC H9 (WA9, Wicell research institute, Madison; USA) (used by UKK
and MRC) were cultured and propagated as described [7]. Cellartis used the com-
mercial hESC and hiPSC cell lines SA181 and ChiPS4, for the generation of HLC
CELhESC and CELhiPSC respectively [9]. HLC generated by MRC were collected after
17 (MRCD17) and 21 (MRCD21) days of differentiation [7]. HLC generated by the
UKK protocol were collected after 18 days of differentiation. Since UKK´s protocol
yields a mixed population of HLC islands and non-HLC, they were harvested as
either as total (UKKtotal) population or as HLC foci (UKKfoci). At least three inde-
pendent experiments (biological replicas) were analyzed for all systems.
Detailed descriptions of the protocols can be found in the Supplementary section
(Supplementary Table 1). A schematic representation of the different cultivation
protocols can be found in Fig. 1A.
Primary human hepatocyte isolation and culture
Primary human hepatocytes were obtained under patient informed consent from
surgical liver resection, following the 1975 Declaration of Helsinki as previously
described [1]. Detailed protocols for isolation and culture of human hepatocytes
in monolayer and sandwich systems are described in Godoy et al. 2013 [1] and
in the Supplementary section.
Microarray analysis
Analysis of gene expression in ESC, HLC and primary hepatocytes was performed
with Affymetrix GenChip Human Genome HG-U133 plus 2.0 chips (Santa Clara,
CA, USA) as previously described [12,13]. Gene expression levels in ESC, HLC and
cultivated primary hepatocytes in collagen monolayer (CM) or collagen sandwichJournal of Hepatology 201(CS) were compared to freshly isolated primary human hepatocytes (FH). Genes
with a fold change greater than two over FH expression levels (p value <0.05,
FDR corrected) were taken as signiﬁcantly deregulated (Supplementary Table 2
for ESC and HLC; Supplementary Tables 3 and 4 for primary hepatocytes in mono-
layer or sandwich cultures respectively).
Bioinformatics
The CellNet platform [11] was used to determine tissue identity based on gene
expression proﬁles of ESC, HLC, and FH. The CellNet algorithm also generates a
metric for GRNs associated with the genes belonging to speciﬁc tissue identities.
The fuzzy c-means algorithm [14] was applied to generate gene clusters with
similar expression patterns in ESC and HLC. Of the twenty clusters identiﬁed by
this approach, we selected those with strongest changes in gene expression,
and created ﬁve cluster groups, containing clusters with similar expression pat-
terns (see Supplementary section for details). Enrichment analysis of gene ontol-
ogy annotation was performed on the gene lists corresponding to each cluster
group, using the manually curated gene ontology database of BioBase
Knowledge Library (BKL) on the ExPlain™ web service (BioBase GmbH,
Wolfenbüttel, Germany). Overrepresented TF binding sites on the promoters of
genes in cluster groups were identiﬁed using the PRIMA (Promoter Integration
in Microarray Analysis) algorithm [15] of the Expander Software 6.1
(EXPression ANalyzer and DisplayER [16].5 vol. 63 j 934–942 935
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Additional information on materials and methods including RNA isolation,
cDNA synthesis, qRT-PCR, immunostaining and ﬂuorescent microscopy are pro-
vided in the Supplementary section.
Results
Genome-wide characterization of ESC-derived hepatocyte-like cells
Human ESC-derived HLC were provided by three different centers
(UKK, MRC, CEL) that focus on developing liver technologies from
hESC and hiPSC. While the goal is the same, the experimental
details and some differentiation factors differ between the proto-
cols used by the three centers (Fig. 1A). The phenotype of HLC
obtained by these protocols has already been published
[3,7,9,17,31,32]. Here, we conﬁrmed the successful hepatic differ-
entiation of HLC by immunoﬂuorescence analysis of albumin,
showing a relatively uniform expression in HLC populations
(Fig. 1B).
To obtain an unbiased assessment of HLC differentiation, we
performed whole genome gene array analysis of ESC as well as
HLC and compared them to freshly isolated primary human hep-
atocytes. Cells were harvested as undifferentiated stem cells (ESC
or hiPSC) or corresponding HLC (scheme for differentiation proto-
cols, Fig. 1A; sample overview: Supplementary Table 1). Since the
UKK differentiation method yields a mixed cell population with
and without hepatocyte-like features, we harvested both whole
cell preparations and HLC foci (Supplementary Fig. 1). A set of
10,420 differentially expressed genes (DEG) was deﬁned for fur-
ther evaluation, which were either differential between FH and
HLC or between FH and ESC or hiPSC (p value <0.05; 2-fold
threshold, FDR adjusted; Supplementary Table 2). Principal com-
ponent analysis (PCA) of the 1000 genes with highest variance
revealed the following features (Fig. 2A): (1) ESC (and hiPSC)
approach primary hepatocytes after differentiation into HLC,
however, they do not fully reach their position suggesting a par-
tial gain of mature hepatic features; (2) although the HLC from
the three centers result in distinct clusters, their overall position
in relation to ESC and FH is close to each other, suggesting thatA B 
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Fig. 2. Partial gain of hepatic differentiation in HLC. (A) Principal component analysis
the three centers. The top two principal components represent 88.5% of the variance
(sandwich) cultures. (B) Heat map representation of the 200 DEG with highest variance in
Representative GO terms and selected genes are indicated for each gene group.
936 Journal of Hepatology 201the three protocols induce similar differentiation features.
Nonetheless, HLC from MRC and CEL were closer to FH than
HLC from UKK. This is also supported by Euclidean distance
(ED) analysis (Supplementary Fig. 2; Supplementary Table 5);
(3) since cultivation of primary hepatocytes induces dedifferenti-
ation associated with massive deregulation of gene expression
[1], we analyzed the gene expression proﬁle of primary human
hepatocytes cultivated for up to 14 days in sandwich and mono-
layer conditions [1]. Interestingly, overall gene expression values
of the primary hepatocytes began to approach stem cell-derived
HLC during the extended period of cultivation (Fig. 2A; EDs in
Supplementary Fig. 3; Supplementary Table 6); (4) the ESC and
hiPSC, although from different sources and cultivated in indepen-
dent labs, cluster closely together. Similarly, the primary freshly
isolated human hepatocytes, although from different donors, also
adopt closely neighboring positions in the PCA; (5) modiﬁcations
of the ﬁnal differentiation steps, such as extending the incubation
period from 17 to 21 days in MRC and the selective collection of
hepatocyte-like foci in UKK had a relatively small inﬂuence on
overall gene expression patterns. The partial hepatic differentia-
tion of HLC was also evidenced by heat map representation and
unsupervised clustering of the 200 genes with highest variance,
followed by gene ontology enrichment analysis (Fig. 2B). For
example, some genes associated with small molecule metabolic
process were induced in HLC to levels comparable to primary
hepatocytes (group 3), while many genes involved in xenobiotic
metabolism remained low (group 4) (Fig. 2B). Likewise, cell
cycle-associated genes were only partially repressed in HLC
(group 1), and several extracellular matrix genes such as collagen
1A2 remained high in HLC compared to primary hepatocytes. In
conclusion, HLC from the three centers were incompletely differ-
entiated when compared to freshly isolated hepatocytes.GRN analysis demonstrates multi-organ differentiation in HLC
To further characterize these HLC, we applied a recently estab-
lished bioinformatics algorithm (CellNet [11]), which assessesPr
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cell identity based on gene expression proﬁles and GRNs [11].
While FH and ESC scored a single tissue classiﬁcation of ‘‘liver’’
and ‘‘esc’’ (respectively), HLC showed a mixed classiﬁcation
including ‘‘liver’’, ‘‘esc’’, ‘‘colon’’ and ‘‘ﬁbroblast’’ (Supplementary
Fig. 4). CellNet also estimates a metric of the GRN associated with
the tissue classiﬁcations. The metric integrates TF inﬂuence over
gene expression, based on experimental approaches including
ChIP-Seq and gene expression proﬁles after TF overexpression
or siRNA-mediated knockdown [11]). ESC and FH scored with a
maximal GRN status (1.0) for ‘‘stem cell’’ and ‘‘liver’’, respectively
(Fig. 3A). All HLC showed a strong but not complete decrease in
the ‘‘esc’’ GRN status, indicating that their stem cell features are
not fully extinguished (Fig. 3A). Conversely, a strong increase in
‘‘liver’’ GRN was detected in all HLC compared with their corre-
sponding ESC (Fig. 3A). Importantly, the ‘‘liver’’ GRN status in
all HLC was higher than in the previously reported iHeps, reach-
ing scores equal or higher than 0.5 in HLC (Fig. 3A), whereas
iHeps only achieved 0.3 [18]. The GRN status also revealed an
increase in ‘‘colon’’ and ‘‘ﬁbroblast’’ status for all HLC (Fig. 3A),
in agreement with the tissue classiﬁcation analysis.
CellNet also generates a ‘‘network inﬂuence score’’ (NIS)
whereby the potential inﬂuence of individual TF on each GRN is
estimated [11]. The ESC network contains TF with known roles
in stem cells such as NANOG and POU5F1B. The NIS of these TF
was high in ESC and strongly reduced in HLC (Fig. 3B).
Nonetheless, other TF such as SALL2 and LIN28A remained with
a high NIS in HLC (Fig. 3B). The NIS for the ‘‘liver’’ GRN identiﬁed
several liver-enriched TF such as FXR (NR1H4), CAR (NR1I3), PXR
(NR1I2), and HNF4, whose low inﬂuence in ESC was partially
increased in all HLC (Fig. 3B). Likewise, NIS analysis identiﬁedG
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Fig. 3. CellNet allows identiﬁcation of multi-tissue GRNs in HLC. (A) Gene regulatory
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induced in all HLC, albeit to lower values than those of ‘‘liver’’ GRN. (B) Identiﬁcation of t
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Journal of Hepatology 201several colon-enriched TF such as KLF5, CDX2, and NKX2-3, whose
inﬂuence increased in HLC compared with their corresponding
ESC (Fig. 3B). The expression of KLF5 and CDX2 were transcrip-
tionally increased in HLC compared to FH (Fig. 4), supporting
the estimation of their activity in HLC. Furthermore, several
colon-enriched genes such as MEP1A and CDH17 were also
strongly induced in HLC (Fig. 4). The NIS of ﬁbroblast-enriched
genes contains genes such as TWIST1 and SNAIL2, known to pro-
mote epithelial to mesenchymal transition (EMT), thereby repre-
senting an ‘‘unwanted’’ feature. Altogether, CellNet unveiled
details of the differentiation stage of HLC, namely the acquisition
of a mixed phenotype with partial loss of stem cell features and
gain of hepatocyte, colon and ﬁbroblast lineages.
Cluster groups identify transcriptional regulators between successful
and insufﬁcient differentiation processes
To further dissect transcriptional mechanisms controlling gene
expression in HLC, we determined differentially expressed TFs
and overrepresentation of TF binding sites (TFBS) in correlated
gene groups. Twenty clusters were formed based on fuzzy
c-means clustering (Supplementary Figs. 6 and 7;
Supplementary Table 6; Supplementary materials and methods)
[14] that were assigned to ﬁve cluster groups (Fig. 5A) (see
Supplementary section).
Cluster group I contains 1057 genes with low expression in
ESC that increased after the HLC differentiation protocols to
levels comparable to those in primary hepatocytes. Conversely,
cluster group II contains 447 genes with low expression in ESC
that were minimally induced after differentiation into HLCColon 
ES
C
 tr
ai
ni
ng
 
FH
 
ES
C
-M
R
C
 
H
LC
-M
R
C
-D
17
 
H
LC
-M
R
C
-D
21
 
ES
C
-C
EL
 
H
LC
-E
SC
-C
EL
 
H
LC
-h
iP
SC
-C
EL
 
hi
PS
C
-C
EL
 
ES
C
1-
U
KK
 
ES
C
2-
U
KK
 
H
LC
-U
KK
-to
ta
l 
H
LC
-U
KK
-f
oc
i
Li
ve
r 
tra
in
in
g gni ni art
nol o
C
FH
 
ES
C
-M
R
C
 
H
LC
-M
R
C
-D
17
 
H
LC
-M
R
C
-D
21
 
ES
C
-C
EL
 
H
LC
-E
SC
-C
EL
 
H
LC
-h
iP
SC
-C
EL
 
hi
PS
C
-C
EL
 
ES
C
1-
U
KK
 
ES
C
2-
U
KK
 
H
LC
-U
KK
-to
ta
l 
H
LC
-U
KK
-f
oc
i
 
 
ELF3 
KLF5 
KLF4 
CDX1 
CDX2 
NKX2-3 
FOXD2 
EHF 
IRF6 
ATOH1 
2 
0 N
IS
 
ES
C
 tr
ai
ni
ng
 
FH
 
ES
C
-M
R
C
 
H
LC
-M
R
C
-D
17
 
H
LC
-M
R
C
-D
21
 
ES
C
-C
EL
 
H
LC
-E
SC
-C
EL
 
H
LC
-hi
PS
C
-C
EL
 
hi
PS
C
-C
EL
 
ES
C
1-
U
KK
 
ES
C
2-
U
KK
 
H
LC
-U
KK
-to
ta
l 
H
LC
-U
KK
-f
oc
i
Li
ve
r 
tra
in
in
g 
Fi
br
ob
la
st
 tr
ai
ni
ng
 
FH
 
ES
C
-M
R
C
 
H
LC
-M
R
C
-D
17
 
H
LC
-M
R
C
-D
21
 
ES
C
-C
EL
 
H
LC
-E
SC
-C
EL
 
H
LC
- h
iP
SC
-C
EL
 
hi
PS
C
-C
EL
 
ES
C
1-
U
KK
 
ES
C
2-
U
KK
 
H
LC
-U
KK
-to
ta
l 
H
LC
-U
KK
-f
oc
i
Fibroblasts
Query 
Training: 
fibroblast
 (1.00) 
2 
0 N
IS
 4 
-2 
-4 
AEBP1 
TWIST2 
NDN 
TWIST1 
TSHZ3 
SNAI2 
HIC1 
FOXF2 
MYOCD 
GLIS2 
Query 
Training: 
colon 
(1.00) 
: 
1.00 
0.75 
0.50 
0.25 
0.00 
1.00 
0.75 
0.50 
0.25 
0.00 
network (GRN) status in FH, ESC and HLC. Bars represent the strength of tissue-
ing set in CellNet, representing the maximum value of 1.0. The ‘‘ESC’’ GRN status is
n of ‘‘liver’’ GRN is observed for all HLC cohorts. The ‘‘colon’’ GRN scores are also
ranscription factors with highest inﬂuence over the ESC, liver and colon GRN. The
each tissue GRN. The heat maps indicate the top ten TF with the highest inﬂuence
5 vol. 63 j 934–942 937
Human protein atlas
Immunohistochemistry RNAseqGene array (ESC-HLC)
KLF5
CDX2
MEP1A
CDH17
14
12
10
8
6
4
2
0
-2
-4
12
10
8
6
4
2
0
-2
245
195
145
95
-5
45
245
195
145
95
-5
45
300
250
150
100
0
50
200
300
250
150
100
0
50
200
350
400
Colon
Duodenum
70
60
40
30
10
20
50
80
90
0
300
250
150
100
0
50
200
350
Small 
intestine
Colon
Duodenum
Small 
intestine
Colon
Duodenum
Small 
intestine
Colon
Esophagus
Ad
ip
os
e 
tis
su
e
Ad
re
na
l g
la
nd
Ap
pe
nd
ix
Bo
ne
 m
ar
ro
w
ce
re
br
al
 c
or
te
x
C
ol
on
D
uo
de
nu
m
Es
op
ha
gu
s
G
al
lb
la
dd
er
H
ea
rt 
m
us
cl
e
Ki
dn
ey
Li
ve
r
Lu
ng
Ly
m
ph
 n
od
e
O
ve
ry
Pa
nc
re
as
Pl
ac
en
ta
Pr
os
ta
te
Sa
liv
ar
y 
gl
an
ds
Sk
in
Sm
al
 in
te
st
in
e
Sp
le
en
St
om
ac
h
Te
st
is
Th
yr
oi
d 
gl
an
d
U
rin
ar
y 
bl
ad
de
r
U
te
ru
s
Ad
ip
os
e 
tis
su
e
Ad
re
na
l g
la
nd
Ap
pe
nd
ix
Bo
ne
 m
ar
ro
w
ce
re
br
al
 c
or
te
x
C
ol
on
D
uo
de
nu
m
Es
op
ha
gu
s
G
al
lb
la
dd
er
H
ea
rt 
m
us
cl
e
Ki
dn
ey
Li
ve
r
Lu
ng
Ly
m
ph
 n
od
e
O
ve
ry
Pa
nc
re
as
Pl
ac
en
ta
Pr
os
ta
te
Sa
liv
ar
y 
gl
an
ds
Sk
in
Sm
al
 in
te
st
in
e
Sp
le
en
St
om
ac
h
Te
st
is
Th
yr
oi
d 
gl
an
d
U
rin
ar
y 
bl
ad
de
r
U
te
ru
s
Ad
ip
os
e 
tis
su
e
Ad
re
na
l g
la
nd
Ap
pe
nd
ix
Bo
ne
 m
ar
ro
w
ce
re
br
al
 c
or
te
x
C
ol
on
D
uo
de
nu
m
Es
op
ha
gu
s
G
al
lb
la
dd
er
H
ea
rt 
m
us
cl
e
Ki
dn
ey
Li
ve
r
Lu
ng
Ly
m
ph
 n
od
e
O
ve
ry
Pa
nc
re
as
Pl
ac
en
ta
Pr
os
ta
te
Sa
liv
ar
y 
gl
an
ds
Sk
in
Sm
al
 in
te
st
in
e
Sp
le
en
St
om
ac
h
Te
st
is
Th
yr
oi
d 
gl
an
d
U
rin
ar
y 
bl
ad
de
r
U
te
ru
s
MRC CEL UKK
ESC
HLC-D17
HLC-D21
ESC
hiPSC
HLC-ESC
HLC-hiPSC
ESC1
ESC2
HLC-total
HLC-foci
Ad
ip
os
e 
tis
su
e
Ad
re
na
l g
la
nd
Ap
pe
nd
ix
Bo
ne
 m
ar
ro
w
ce
re
br
al
 c
or
te
x
C
ol
on
D
uo
de
nu
m
Es
op
ha
gu
s
G
al
lb
la
dd
er
H
ea
rt 
m
us
cl
e
Ki
dn
ey
Li
ve
r
Lu
ng
Ly
m
ph
 n
od
e
O
ve
ry
Pa
nc
re
as
Pl
ac
en
ta
Pr
os
ta
te
Sa
liv
ar
y 
gl
an
ds
Sk
in
Sm
al
 in
te
st
in
e
Sp
le
en
St
om
ac
h
Te
st
is
Th
yr
oi
d 
gl
an
d
U
rin
ar
y 
bl
ad
de
r
U
te
ru
s
Fig. 4. Identiﬁcation of colon-associated genes in HLC. The graphs on the left indicate the mRNA expression levels of the transcription factors KLF5 and CDX2, and the
colon genes MEP1A and CDH17, in ESC and HLC. The tissue speciﬁcity for these genes was validated by querying the Proteinatlas [30]. Here, representative pictures of
immunostainings for the aforementioned genes are shown, indicating the nuclear expression of KLF5 and CDX2 in colon crypts, and the membranous expression of MEP1A
and CDH17. The colon-enriched expression for these genes is also shown at the transcriptional level (RNAseq).
Research Article(Fig. 5A). Cluster groups I and II are enriched in GO categories
associated with mature liver functions, including ‘‘metabolic pro-
cess’’ (GO:00081), ‘‘catalytic activity’’ (GO:00038) and ‘‘immune
system process’’ (GO:00023) (Fig. 5A, representative genes in938 Journal of Hepatology 201Supplementary Table 8). Hence, cluster group I represents suc-
cessful hepatocyte differentiation of HLC, while the genes in clus-
ter group II did not reach the levels of hepatocytes. Cluster group
I contains several transcription factors with known roles in5 vol. 63 j 934–942
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Fig. 5. Cluster groups unveil detailed features of complete and partial hepatic
differentiation of HLC. (A) After establishing 20 fuzzy clusters representing
distinct gene expression patterns on HLC (see Supplementary section), ﬁve cluster
groups were formed selecting clusters containing genes with average fold
changes over ﬁve fold (see Supplementary section for detailed descriptions). The
Cluster groups contain 3217 genes, allowing for a more robust and precise
bioinformatics analysis. The most relevant biological motifs and representative
genes are shown. Furthermore, the potential transcriptional control mechanisms
such as deregulated (representative) transcription factors and overrepresented
TFBS are shown. (B–C) Real time quantitative PCR analysis of selected transcrip-
tion factors in ESC and HLC-MRC at 17 and 21 days of differentiation. Expression
levels were normalized to those in freshly isolated hepatocytes. Bars correspond
to mean values ± standard error of the mean. Representative of three independent
biological replicas.
JOURNAL OF HEPATOLOGYhepatocyte differentiation [19], including transcriptionally
upregulated HNF1A, HNF4A, CEBPA, CEBPD, and CEBPD (Fig. 5A,
Supplementary Table 9). The upregulation of these TF was con-
ﬁrmed by quantitative real time PCR (Fig. 5B). Furthermore, the
binding site for HNF1 was signiﬁcantly overrepresented in cluster
I (Fig. 5A; Supplementary Table 10). The increased expression of
these TF is consistent with the successful hepatocyteJournal of Hepatology 201differentiation of HLC, since their role as inducers of
liver-speciﬁc genes is well-established [19]. Cluster group II also
contains TF controlling liver metabolic functions, such as CAR,
FXR, SHP, PXR (Fig. 5A and Supplementary Table 9). In contrast
with TF of cluster group I, these TF were only slightly induced
in HLC (Fig. 5A, B; Supplementary Table 9). The low expression
of these TF in HLC is consistent with the NIS results for the ‘‘liver’’
GRN. The binding site for HNF1 was also overrepresented in clus-
ter group II. The complexity of the GRNs is illustrated by the fact
that overrepresented binding sites of HNF1 appear in both, clus-
ter I and II. The difference between both clusters may be due to
HNF1 interaction partners. Notably, FXR and PXR, known to func-
tionally interact with HNF1, also show low expression levels in
HLC (Fig. 5 and Supplementary Table 9).
Cluster group III contains 1562 genes whose expression was
high in ESC and strongly decreased during differentiation into
HLC (Fig. 5A). Conversely, cluster group IV contains 101 genes
with high expression levels in ESC that did not decrease to the
levels of FH during the differentiation process (Fig. 5). Cluster
group III is enriched in GO terms such as ‘‘cell cycle’’
(GO:0007049) and ‘‘regulation of mitosis’’ (GO:0007088)
(Supplementary Table 8). Genes in these categories include
cyclins as well as cyclin-dependent kinases, and TF and TFBS,
such as E2F5 and MYB (Fig. 5; Supplementary Tables 9–10). The
downregulation of cell cycle-associated genes suggests repres-
sion of the self-renewal potential, a well-known feature of stem
cell differentiation. Cluster IV also contains GO terms associated
to cell cycle such as ‘‘regulation of nuclear division’’ and ‘‘regula-
tion of mitosis’’, and included genes such as CCNB1, CDK1, ECT2,
TOP2A, and TTK. Although the expression of these genes was
downregulated in HLC compared to stem cells, their levels
remained above those of primary hepatocytes (Fig. 5A;
Supplementary Table 8). It contains only one TF, namely SOX11
(Supplementary Table 9). The observation that cell
cycle-associated genes were not fully downregulated in HLC
prompted us to determine the expression levels of the represen-
tative TF identiﬁed by our analysis by real time qPCR (Fig. 5C).
While MYB expression was strongly reduced in HLC, the levels
of E2F5 and SOX11 remained elevated (Fig. 5C), suggesting that
they may be responsible for the sustained expression of cell
cycle-associated genes in cluster group IV.
Cluster group V contains genes whose expression is at least
4-fold higher in stem cells compared to hepatocytes and which
further increase during differentiation. This cluster shows over-
representation of GO terms such as ‘‘extracellular region’’
(GO:0005576) and ‘‘cell migration’’ (GO:0016477) (Fig 5A;
Supplementary Table 8). Genes in these categories include extra-
cellular matrix genes such as collagens (e.g. COL1A1, COL12A1),
other matrix proteins (FBN1, LAMB3, LAMA5), integrins (e.g.
ITGA3, ITGA6, ITGAV) and cytokines (EGF, WNT5A). The deregu-
lated TF identiﬁed in this cluster group, including FOXQ1, YBX3,
TWIST1, and SOX4, may be responsible for the not fully differen-
tiated phenotype of HLC (Fig. 5 and Supplementary Table 9).
For example, FOXQ1 is an oncogene found overexpressed in col-
orectal [20] and breast cancer [21], where it induces proliferation,
dedifferentiation and EMT. FOXQ1 is also overexpressed in hepa-
tocellular carcinoma and induces metastasis [22]. Similarly, YBX3
can induce proliferation and dedifferentiation [23,24]. The upreg-
ulation of these TF in HLC was also demonstrated by real time
qPCR analyzes (Fig. 5C). Therefore, they represent an undesirable
outcome of the differentiation process.5 vol. 63 j 934–942 939
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In conclusion, cluster group analysis reveals gene groups rep-
resenting successful and failed outcomes in HLC differentiation.
Furthermore, we identify key TF responsible for aberrant expres-
sion clusters, thereby giving a basis for overexpression or knock-
down approaches to improve HLC differentiation.
Culture-dependent repression of liver metabolism genes
It is well-known that primary hepatocytes dedifferentiate in cul-
ture, whereby expression of many metabolic genes decreases.
Interestingly, in vitro dedifferentiated primary hepatocytes
resemble stem cell-derived HLC more closely than freshly iso-
lated hepatocytes, which can be seen from the PCA (Fig. 2A)
and can also be objectiﬁed by the analysis of EDs
(Supplementary Fig. 3; Supplementary Table 6). Therefore, one
might hypothesize that if the same genes which decrease during
cultivation in primary hepatocytes, also remain low after differ-
entiation of stem cells into HLC, this is due to the the creation
of a sub-optimal liver niche in cell culture. To test this hypothesis,6
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Fig. 6. Comparable repression of metabolism-associated genes during culti-
vation of primary hepatocytes and differentiated HLC. (A) Correlation between
genes repressed in primary hepatocytes after 14 days of cultivation in 2D
(monolayer) conditions and genes deregulated in HLC (UKK-islands) compared to
FH. The red dots represent the top 10%, while the purple and green dots
correspond to the additional 20 and 40% genes with highest correlation. (B) Venn
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correlated genes with genes in cluster group II (Fig. 5). The light blue circles
represent genes in each cluster group as described in Fig. 5. Red circles represent
genes in the top 10 to 40% with highest correlation, as described in A.
940 Journal of Hepatology 201we analyzed the correlation between downregulated genes after
14 days of monolayer culture of primary hepatocytes and the dif-
ference between HLC vs. freshly isolated hepatocytes (gene
expression in HLC minus expression in freshly isolated hepato-
cytes) (Fig. 6A). Interestingly, a highly signiﬁcant correlation
was obtained (p <0.001; R = 0.54). We further analyzed the 10,
20, and 40% genes with the highest correlation coefﬁcients, indi-
cated by red, purple and green colors respectively in Fig. 6A.
Interestingly, these genes belong predominantly to the aforemen-
tioned cluster group II (Fig. 6B). This correlation remained even
when including the top 20 or 40% genes (Fig. 6B). As described
above, metabolism-associated GO terms are overrepresented in
this cluster group. Similarly, metabolism GO terms were enriched
in the top 10 to 40% correlated genes (Supplementary Table 11).
All these metabolism-associated genes are expressed at much
lower levels in HLC than in primary hepatocytes, independent
of which of the three differentiation protocols (MRC, CEL, UKK)
the HLC were obtained (Supplementary Table 12). The same
genes were also downregulated during a 14 days cultivation per-
iod of primary hepatocytes, when the hepatocytes were kept in
2D monolayer cultures (Supplementary Table 12). To see if
decreased expression of metabolic genes is explained by the cul-
ture conditions we also used a 3D culture system, where hepato-
cytes were cultivated between two layers of soft gel collagen
(Supplementary Table 12). 3D culture ameliorated or abolished
the decrease in expression for some genes including ADH1C,
CYP4F2, CYP7A1, and HSD11B1, but the situation remained similar
for the majority of genes. In conclusion, mechanisms inherent to
in vitro cultivation systems antagonize the differentiation
towards mature liver, affecting both the stability of primary hep-
atocytes and the potential for gain of liver functions in HLC.Discussion
The differentiation of human embryonic stem cells (hESC) to HLC
and the advent of induced pluripotency seem to open exciting
new possibilities to generate an unlimited supply of human
hepatocytes for numerous applications [2,25]. Indeed, recent
studies reported that pluripotent stem cell derived HLC and
transdifferentiated iHep ‘exhibited hepatic functions’ comparable
to cryopreserved human hepatocytes [7,4,10]. However, also
more critical viewpoints about the differentiation status of HLC
have been published [26,18]. The present genome-wide study
demonstrates that the interpretation of stem cell derived or
transdifferentiated-derived HLC as almost fully differentiated
hepatocytes might be further away than previously suggested.
In reality, a mixed population of cells are produced which express
genes representative of liver, colon, stem cells and/or ﬁbroblasts.
This seems to be in agreement with principles of embryonic
development. After gastrulation, the naive endoderm transforms
into a primitive gut tube which becomes regionalized into fore-
gut, midgut, and hindgut domains. As development proceeds,
the foregut gives rise to the liver, while the hindgut forms the
large intestine. In line with this, a recent proteomics approach
demonstrated that HLC resemble embryonic rather than mature
liver [27]. Results of the present GRN analysis show that HLC rep-
resent a population of cells that possess mixed features with high
expression of colon-associated TF such as KLF5, CDX2, and
NKX2-3 (Supplementary Fig. 12). To further differentiate HLC to
mature hepatocytes it will be useful to understand the cell5 vol. 63 j 934–942
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populations which exist in vitro and modulate transcription fac-
tors responsible for colon development. However, care must be
taken with this approach as colon transcription factors, such as
CDX2, also modulate HNF4a DNA occupancy and gene expression
[33].
A strength of the present study is that GRN analysis of HLC
established by three different labs resulted in very similar conclu-
sions. Moreover, cluster analysis demonstrated that gene expres-
sion alterations during the differentiation process fall into ﬁve
distinct groups. Cluster group I supports the ‘favorable’ interpre-
tation obtained in several previous studies. It contains genes
strongly upregulated during the differentiation process that are
involved in hepatic metabolism (Supplementary Table 11).
However, it should be considered that also cluster group II con-
tains genes representative of normal liver functions, such as
metabolism and synthesis of coagulation and complement fac-
tors. In contrast to cluster I they remain orders of magnitudes
lower than those in primary hepatocytes. Interestingly, cluster
II genes largely overlap with genes whose expression decreases
during cultivation of primary hepatocytes (Fig. 5). This striking
overlap could mean that key mechanisms responsible for mainte-
nance of the liver’s metabolic genes are generally absent in vitro.
Discovery of factors that maintain expression of cluster IV genes
in primary hepatocytes may also help to improve stem cell differ-
entiation. The binding site of HNF1, a TF involved in expression of
genes characteristic of differentiated hepatocytes [19] is overrep-
resented in cluster group II genes; further ‘liver transcription fac-
tors’, such as CAR, FXR, PXR are upregulated during stem cell
differentiation but only to levels much lower than those observed
in primary hepatocytes.
The second ‘favorable’ cluster group III contains proliferation
associated genes that are suppressed during the differentiation
process, thereby approaching the low expression levels of pri-
mary hepatocytes. In contrast, cluster group IV contains also pro-
liferation associated genes, but expression levels stay higher
compared to primary hepatocytes. SOX11 seems to represent a
critical transcription factor for these genes. Cluster group V con-
tains genes whose expression is upregulated in comparison to
levels in mature hepatocytes. These genes include extracellular
matrix proteins and integrins as well as the TF TWIST1which pre-
viously have been reported to be upregulated when primary hep-
atocytes dedifferentiate in culture [28,29,13]. These
‘‘unfavorable’’ clusters (II, IV and V) contain only 1053 genes
(28.7%) compared to the much higher number of 2619 genes
(71.3%) of the favorable clusters (I and III). Therefore, the majority
of genes whose expression is inﬂuenced during differentiation
approach levels similar to those observed in hepatocytes.
Nevertheless, a major hurdle on the path to stem cell-derived
hepatocytes are control mechanisms of gene cluster groups II,
IV and V. Since the transcription factors controlling their expres-
sion have been identiﬁed in this study, research in the future
should aim at adjusting their activity to levels of primary
hepatocytes.
In addition to hESC-derived HLC, three independent batches of
hiPSC-HLC were analyzed. Bioinformatic analyzes demonstrate a
high degree of similarity to hESC-HLC considering the position in
the PCA and cluster analysis. A minor difference is that the prolif-
eration associated cluster group III genes were lower in
hiPSC-HLC compared to hESC-HLC. Differences between
hESC-HLC populations were also noted, with the stronger sup-
pression of ESC gene network features in CEL-HLC compared toJournal of Hepatology 201those from UKK and MRC (Fig. 3). While promising, the CEL pro-
tocol also resulted in enhanced colon network features when
compared to the other HLC. This illustrates that more efﬁcient
suppression of ESC features does not necessarily lead to enhanced
hepatocyte but may enhance the ‘‘unwanted’’ colon features.
In conclusion, the present unbiased, genome-wide study
reveals the strengths and limitations of current protocols aiming
at generating hepatocytes from hESC or hiPSC. The observation of
mixed cell speciﬁcation, the deﬁnition of ﬁve cluster groups, and
their assignment to key TF give a basis to radically improve future
differentiation protocols.Financial support
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